Published in Endocrinology on May 01, 1990
Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sci U S A (1992) 0.95
Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. Proc Natl Acad Sci U S A (1991) 0.89
Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis. Ann Rheum Dis (2004) 0.81
Genetic variability in adult bone density among inbred strains of mice. Bone (1996) 3.66
Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol (1987) 3.28
Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res (2001) 2.94
Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev (1997) 2.63
Myogenic differentiation in permanent clonal mouse myoblast cell lines: regulation by macromolecular growth factors in the culture medium. Dev Biol (1981) 2.20
Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone (1997) 2.09
IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol (2002) 2.01
Incorporation of sodium fluoride into cortical bone does not impair the mechanical properties of the appendicular skeleton in rats. Calcif Tissue Int (1992) 1.95
Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci U S A (2000) 1.90
Control of mouse myoblast commitment to terminal differentiation by mitogens. J Supramol Struct (1980) 1.89
Glucocorticoid-induced osteoporosis. N Engl J Med (1983) 1.74
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2001) 1.70
Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm Genome (1999) 1.68
Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab (1994) 1.63
Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass. Metabolism (1977) 1.61
Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat. Science (1975) 1.60
Preventing excessive gestational weight gain: a systematic review of interventions. Obes Rev (2010) 1.53
Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone (1996) 1.53
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int (2000) 1.52
Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int (1995) 1.51
Quantification of skeletal alkaline phosphatase in osteoporotic serum by wheat germ agglutinin precipitation, heat inactivation, and a two-site immunoradiometric assay. Clin Chem (1994) 1.50
Phosphotyrosyl protein phosphatases. Biochem J (1989) 1.49
Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum (1993) 1.42
Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism (1984) 1.41
Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective. Chest (1992) 1.40
Bone growth factors. Clin Orthop Relat Res (1991) 1.39
Exercise and mechanical loading increase periosteal bone formation and whole bone strength in C57BL/6J mice but not in C3H/Hej mice. Calcif Tissue Int (2000) 1.36
Identification of wound healing/regeneration quantitative trait loci (QTL) at multiple time points that explain seventy percent of variance in (MRL/MpJ and SJL/J) mice F2 population. Genome Res (2001) 1.35
Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res (2000) 1.35
Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest (1975) 1.33
Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem (1981) 1.33
Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells. Science (1983) 1.32
Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest (2001) 1.32
Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism (1983) 1.32
Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice. J Bone Miner Res (2001) 1.31
Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab (1989) 1.31
Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology (2001) 1.28
Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. Proc Natl Acad Sci U S A (1981) 1.25
The insulin-like growth factor system and the coupling of formation to resorption. Bone (1995) 1.24
Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem (1995) 1.23
The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels. Clin Endocrinol (Oxf) (1976) 1.23
Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J Cell Physiol (1988) 1.22
Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest (1976) 1.22
Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4. Mol Ther (2001) 1.20
Inhibition of bone formation during space flight. Science (1978) 1.19
Bone formation by osteocytes. Am J Physiol (1971) 1.17
Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology (1999) 1.16
Quantitative trait loci for bone density in mice: the genes determining total skeletal density and femur density show little overlap in F2 mice. Calcif Tissue Int (2002) 1.16
Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res (1998) 1.16
In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc Natl Acad Sci U S A (1980) 1.15
Distribution of acid and alkaline phosphatase activity in undemineralized sections of the rat tibial diaphysis. J Histochem Cytochem (1969) 1.14
Production and release of acetylcholinesterase by cultured chick embryo muscle. Dev Biol (1973) 1.14
Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis? Lancet (1982) 1.14
Quantitative histological studies on the pathogenesis of uremic bone disease. J Clin Endocrinol Metab (1974) 1.13
Genetic control of the rate of wound healing in mice. Heredity (Edinb) (2001) 1.13
Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab (1995) 1.12
Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res (1999) 1.12
Hip mineral density in females with a recent hip fracture. J Clin Endocrinol Metab (1992) 1.11
Analysis of gene expression in the wound repair/regeneration process. Mamm Genome (2001) 1.10
Studies on the potential mediators of skeletal changes occurring during puberty in girls. J Clin Endocrinol Metab (1999) 1.09
Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. J Endocrinol (2005) 1.09
Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors (1990) 1.07
Genetic regulation of femoral bone mineral density: complexity of sex effect in chromosome 1 revealed by congenic sublines of mice. Bone (2007) 1.06
Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab (1990) 1.05
In vitro metabolism of 25-hydroxyvitamin D3 by isolated rat kidney cells. Proc Natl Acad Sci U S A (1980) 1.05
Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo. Bone (1996) 1.04
Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. Proc Natl Acad Sci U S A (1989) 1.04
Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim Biophys Acta (1988) 1.04
Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am (1994) 1.04
Quantitation of growth factors IGF-I, SGF/IGF-II, and TGF-beta in human dentin. J Bone Miner Res (1990) 1.02
Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J Clin Endocrinol Metab (2001) 1.02
Calcium and phosphorus deficiency in rats: effects on PTH and 1,25-dihydroxyvitamin D3. Am J Physiol (1979) 1.01
Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology (1989) 1.00
Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat. Endocrinology (1975) 1.00
Purification of a skeletal growth factor from human bone. Biochemistry (1982) 1.00
Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice. Bone (2000) 1.00
Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat. Endocrinology (1977) 1.00
Fluoride and bovine bone extract influence cell proliferation and phosphatase activities in human bone cell cultures. Clin Orthop Relat Res (1988) 0.99
Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun (1991) 0.99
Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Arch Biochem Biophys (2000) 0.99
Quantitative trait loci for periosteal circumference (PC): identification of single loci and epistatic effects in F2 MRL/SJL mice. Bone (2003) 0.99
Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin. Clin Chem (1981) 0.99
A new rat model simulating some aspects of space flight. Physiologist (1979) 0.98
Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies. J Clin Endocrinol Metab (2001) 0.98
Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab (1990) 0.98
Human skeletal alkaline phosphatase. Kinetic studies including pH dependence and inhibition by theophylline. J Biol Chem (1980) 0.98
A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program. Nutr Diabetes (2013) 0.98
Structure-function analysis of the human insulin-like growth factor binding protein-4. J Biol Chem (1998) 0.97
Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts. Growth Horm IGF Res (2005) 0.96
Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities. J Bone Miner Res (1999) 0.96
Differential protein profile in the ear-punched tissue of regeneration and non-regeneration strains of mice: a novel approach to explore the candidate genes for soft-tissue regeneration. Biochim Biophys Acta (2000) 0.96